Clinical Policy Title: Genetic tests for Duchenne muscular dystrophy
ثبت نشده
چکیده
CP# 02.01.01 Maternal genetic testing CP# 02.01.02 Genetic testing for breast and ovarian cancer CP# 02.01.03 Array comparative genomic hybridization testing CP# 02.01.13 Pharmacogenetic testing for warfarin CP# 02.01.07 Genetic testing for cystic fibrosis CP# 02.01.08 Familial polyposis gene testing CP# 02.01.10 COLARIS® test for Lynch syndrome CP# 02.01.11 AfirmaTM gene expression classifier for indeterminate thyroid nodules CP# 02.01.12 Corus coronary artery disease (CAD) for genomic expression CP# 02.01.14 Gene expression profile testing for breast cancer CP# 05.01.04 Molecular analysis for targeted therapy of non-small cell lung cancer
منابع مشابه
Detection of the Duplication in Exons 56-63 of Duchenne Muscular Dystrophy Patients with MLPA
Background Duchenne Muscular Dystrophy (DMD) is a deadly X-linked recessive disorder. This genetic disorder affects 1 among 3,500-5,000 males in the world. The majority of the patients are male, due to the type of inheritance. It affects most of the skeletal, the respiratory, and cardiac muscles, causing these vital organs to contract and eventually mortality.<br...
متن کاملP164: Adeno-Associated Viral Vectors in Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (BMD) is an inherited X-link disease. The incidence of this muscle-wasting disease is 1:5000 male live births. Mutation in the gene coding for dystrophin is the main cause of BMD. Most cases of this disease succumb to respiratory and cardiac failure in 3rd to 4th decades. The slow progression of BMD and recent achievement of gene therapies make it as an appropriate c...
متن کاملCardiovascular Health Supervision for Individuals Affected by Duchenne or Becker Muscular Dystrophy
Duchenne muscular dystrophy is the most common and severe form of the childhood muscular dystrophies. The disease is typically diagnosed between 3 and 7 years of age and follows a predictable clinical course marked by progressive skeletal muscle weakness with loss of ambulation by 12 years of age. Death occurs in early adulthood secondary to respiratory or cardiac failure. Becker muscular dystr...
متن کاملDelay in Diagnosis of Duchenne Muscular Dystrophy
Investigators from Johns Hopkins Hospital, Baltimore, MD, retrospectively reviewed 179 records of patients with Duchenne muscular dystrophy (DMD) evaluated between 1989 and 2012. Diagnosis was confirmed by genetic testing or muscle biopsy, and clinical data were complete in 107 patients.
متن کامل